Lasa Supergenerics Limited — Board Meeting, 28-05-2025: Outcome of Board Meeting

Lasa Supergenerics has announced a board meeting that approved its audited financial results for the quarter and year ended March 31, 2025. The company reported a net loss before tax of Rs 19.38 Cr, driven by a Rs 23.91 Cr loss from selling two units. Total assets and equity saw a sharp increase year-on-year, reflecting big operational shifts. After year-end, a factory fire caused significant damage to inventory and assets, with losses still being assessed. Management remains focused on recovery and confident about ongoing business stability.